TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 3 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $250,000 | -53.9% | 532,455 | -31.5% | 0.00% | – |
| Q3 2016 | $542,000 | -61.5% | 777,440 | +10.0% | 0.00% | – |
| Q2 2016 | $1,407,000 | -16.2% | 707,065 | +1.5% | 0.00% | – |
| Q1 2016 | $1,678,000 | -55.3% | 696,534 | +42.3% | 0.00% | – |
| Q4 2015 | $3,755,000 | +58.1% | 489,580 | +9.1% | 0.00% | – |
| Q3 2015 | $2,375,000 | -26.9% | 448,874 | +23.9% | 0.00% | – |
| Q2 2015 | $3,250,000 | +46.5% | 362,360 | +3.2% | 0.00% | – |
| Q1 2015 | $2,218,000 | +55.5% | 350,960 | +43.7% | 0.00% | – |
| Q4 2014 | $1,426,000 | -12.2% | 244,160 | +3.0% | 0.00% | – |
| Q3 2014 | $1,624,000 | -43.4% | 237,060 | +18.6% | 0.00% | – |
| Q2 2014 | $2,869,000 | +41.7% | 199,913 | +2.8% | 0.00% | – |
| Q1 2014 | $2,025,000 | +427.3% | 194,513 | +423.0% | 0.00% | – |
| Q4 2013 | $384,000 | – | 37,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 800,000 | $1,592,000 | 1.06% |
| PURA VIDA INVESTMENTS, LLC | 284,877 | $567,000 | 0.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,097,248 | $4,174,000 | 0.23% |
| Broadfin Capital, LLC | 433,911 | $863,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 585,914 | $1,166,000 | 0.06% |
| FNY Managed Accounts LLC | 26,000 | $51,740,000 | 0.05% |
| BLUESTEIN R H & CO LLC | 175,905 | $350,000 | 0.03% |
| FT Options LLC | 15,000 | $30,000 | 0.03% |
| Klingman & Associates, LLC | 10,000 | $20,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 103,900 | $207,000 | 0.00% |